Ukraine’s healthcare system – resilience under fire
Ukraine's health minister Viktor Lyashko pushes for 'business as usual' as Russia invades, but ingenuity and support are needed.
By
Janet Beal
All Articles
The UK’s first drug approval via Project Orbis – pulling away from the EMA strings?
In early May, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approved a targeted anticancer drug, AstraZeneca’s Tagrisso…
By
UK bans parallel export of two COVID-19 treatment candidates to protect national supply
While the UK has not yet seen a major cluster of infections in the current major international outbreak of…
By
Zolgensma may be a potential game-changer for SMA
Within the next month, the US Food and Drug Administration (FDA) is set to review a landmark gene therapy…
By
So, was this worth the wait?…the UK government finally responds to last year’s Accelerated Access Review
It has taken a while, but at long last the UK government has issued its much-anticipated response to the Accelerated…
By
Time for a consultation on the impact of Brexit on the UK’s access to medicines: Better late than never?
In a move which might best be described with the understatement “well, about time…”, the UK’s cross-parliamentary select committee…
By
Can Affordable Medicines become a reality for Ukraine?
A recent survey, “Cost(less) Medicine”, commissioned by the United States Agency for International Development (USAID) and conducted by the…
By
Big dreams versus cost-saving schemes – will the UK dare to pursue its Accelerated Access ambitions in cash-strapped times?
The UK’s Accelerated Access Review was finally published last month. Its remit was always going to be a difficult…
By